Corrected: BRIEF-Oryzon Genomics H1 Net Loss At €1.4 Mln
28/07/2026 06:14
CORRECTED-BRIEF-Oryzon Genomics H1 Net Loss At €1.4 Mln Adds missing currency
July 28 (Reuters) - Oryzon Genomics SA ORY.MC:
SAID ON MONDAY, H1 NET LOSS €1.4 MILLION
Source text
Further company coverage: ORY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28